(Q33982161)

30 July 2017

HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis (English)

1 reference

30 July 2017

0 references

3

Walid Heneine

1 reference

30 July 2017

4

Sally Blower

1 reference

PubMed ID

20616092

30 July 2017

J Gerardo Garcia-Lerma

series ordinal

2

object named as

J Gerardo García-Lerma

1 reference

30 July 2017

Virginie Supervie

1

1 reference

PubMed ID

20616092

30 July 2017

language of work or name

English

0 references

publication date

28 June 2010

1 reference

Proceedings of the National Academy of Sciences of the United States of America

30 July 2017

1 reference

30 July 2017

107

1 reference

30 July 2017

27

1 reference

30 July 2017

12381-12386

1 reference

Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Pre-exposure prophylaxis for HIV infection: what if it works?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Stability of transmitted drug-resistant HIV-1 species

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Could disease-modifying HIV vaccines cause population-level perversity?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901470

Antiretroviral-drug resistance among patients recently infected with HIV.

5 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Preexposure prophylaxis for HIV: unproven promise and potential pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Changing Transmission Fitness of Drug‐Resistant Human Immunodeficiency Virus against a Background of Evolving Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Long-term persistence of primary genotypic resistance after HIV-1 seroconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Phospholipase D in the human ocular surface and in pterygium

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Chemoprophylaxis of HIV Infection: Moving Forward with Caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1006061107

Changes in prevalence of HIV infection and sexual risk behavior in men who have sex with men in San Francisco: 1997 2002

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20616092

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prevalence of detection and dynamics of selection and reversion of K65R mutation in nucleoside reverse transcriptase inhibitor-experienced patients failing an antiretroviral regimen

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20616092

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20616092

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.1006061107

1 reference

30 July 2017

0 references

1 reference

30 July 2017

1 reference

PubMed ID

20616092